North American Drug Delivery Technologies Market worth $102.2 Billion By 2017 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

North American Drug Delivery Technologies Market worth $102.2 Billion By 2017

Description:

The North American market was valued at $66.7 billion in 2012 and is poised to reach $102.2 billion by 2017. The U.S. registered a higher market share, valued at $59.3 billion in 2012 and is expected to grow at a high single digit CAGR from 2012 to 2017. – PowerPoint PPT presentation

Number of Views:61

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: North American Drug Delivery Technologies Market worth $102.2 Billion By 2017


1
MarketsandMarkets Presents
North American Drug Delivery Technologies Market
worth 102.2 Billion By 2017

2
  • The North American Drug Delivery Technologies
    Market (Metered Dose Inhalers, Needle-Free
    Injectors, Auto-Injectors, Nasal Sprays,
    Transdermal Patches, Nebulizers, Infusion Pumps,
    Drug Eluting Stents, Sustained Release, Ocular
    Implants) Forecasts to 2017 analyzes and studies
    the major market drivers, restraints, and
    opportunities in North America.
  • Browse 95 market data tables with 28 figures
    spread through 267  pages and in-depth TOC on "
    North American Drug Delivery Technologies Market
    (Metered Dose Inhalers, Needle-Free Injectors,
    Auto-Injectors, Nasal Sprays, Tran dermal
    Patches, Nebulizers, Infusion Pumps, Drug Eluting
    Stents, Sustained Release, Ocular Implants)
    Forecasts to 2017" 
  • http//www.marketsandmarkets.com/Market-Reports/no
    rth-american-drug-delivery-technologies-market-120
    9.html
  • Early buyers will receive 10 customization on
    reports.

3
  • This report studies the North American Drug
    Delivery Technologies  Market over the forecast
    period of 2012 - 2017.
  • The North American market was valued at 66.7
    billion in 2012 and is poised to reach 102.2
    billion by 2017. The U.S. registered a higher
    market share, valued at 59.3 billion in 2012 and
    is expected to grow at a high single digit CAGR
    from 2012 to 2017. The Canadian market is also
    growing at a decent CAGR of 7.9, to reach 10.7
    billion by 2017.
  • The U.S. Supreme courts decision to uphold the
    healthcare reforms is expected to substantially
    increase the number of insured citizens in the
    U.S. This will thereby boost the market for novel
    drug delivery technology based formulations and
    devices. In addition, the rising number of drug
    approvals by Health Canada, serves as an
    opportunity for the Canadian market.
  • The acquisitions of Eurand Pharmaceuticals
    (Netherlands) by Aptalis Pharma(U.S.),  Labopharm
    (Canada) by Paladin Labs (Canada), and CIMA Labs
    (U.S.) and Cephalon by Teva Pharmaceuticals
    (Israel) constitute the major developments in the
    North American market.

4
  • Also, there are significant developments in the
    field of targeted drug delivery (using liposomes
    and nanoparticle drug carriers) owing to the
    advancements in polymers and biopolymers
    technology for small molecules, macromolecules,
    and prodrugs.
  • The growth of the market is driven by the
    increasing adoption of drug delivery technologies
    by pharmaceutical and medical device companies in
    North America, and greater patient acceptability
    of drug delivery products. The opportunities for
    the growth of this market include developments of
    drug deliverytechnologies for non-conventional
    therapeutic applications and for use in home
    setting. Other factors like collaborations of
    drug delivery firms with pharmaceutical firms
    also offer opportunities to the drug delivery
    firms, as they could assist pharmaceutical
    companies with their manufacturing services
    technology platforms, product development, and
    regulatory procedures. However, in the past and
    present, product recalls of drug delivery
    products is one factor that hampered the growth
    of this market and also raised concerns on RD
    expenditure for development of such products.

5
  • This research report categorizes the North
    American drug delivery technologies market by
    routes of administration it includes oral,
    pulmonary, transdermal, inject able, ocular,
    nasal, topical, implantable, and transmucosal
    technologies. All these market segments are
    further divided into sub-segments that comprise
    of formulations or devices, to provide exhaustive
    value analysis for the years 2010, 2011, 2012,
    and forecast to 2017. The North American market
    for oral drug delivery technologies was estimated
    at 25.4 billion in 2012 and is expected to grow
    at a healthy CAGR of 8.6 from 2012 to 2017. Oral
    technologies offer easier and cost-effective
    reformulation strategies hence they occupy the
    largest share in the market. On the other hand,
    pulmonary technologies market is expected to grow
    at the highest CAGR of 11.8, due to the
    increased adoption rates of pulmonary devices and
    their expanding applications. This market is
    poised to reach 23.1 billion by 2017.
  • Key players in the market are 3M Company (U.S.),
    Aptalis Pharma, Inc. (U.S.), Baxter
    International, Inc. (U.S.), Becton Dickinson
    Co. (U.S.), Catalent Pharma Solutions (U.S.),
    Cipher Pharmaceuticals (Canada), Dow Chemical
    Company (U.S.), Endo Pharmaceuticals (U.S.),
    Johnson Johnson (U.S.), Nektar Therapeutics
    (U.S.), OptiNose (U.S.), QLT (Canada), and
    Valeant Pharmaceuticals (Canada).

6
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets
7
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
About PowerShow.com